ELAVL1 and breast cancer: To our knowledge, this is the first study to demonstrate that hsa_circ_0067842 affects metastasis and immune escape of BC through the HuR/CMTM6/PD-L1 axis, providing new ideas for BC research and potential molecular targets for the prognosis and treatment of BC.